Litcius/Paper detail

Impact of Aneuploidy and Chromosome 9p Loss on Tumor Immune Microenvironment and Immune Checkpoint Inhibitor Efficacy in NSCLC

Joao V. Alessi, Xinan Wang, Arielle Elkrief, Biagio Ricciuti, Yvonne Y. Li, Hersh Gupta, Liam F. Spurr, Hira Rizvi, Jia Luo, Federica Pecci, Giuseppe Lamberti, Gonzalo Recondo, Deepti Venkatraman, Alessandro Di Federico, Malini Gandhi, Victor R. Vaz, Mizuki Nishino, Lynette M. Sholl, Andrew D. Cherniack, Marc Ladanyi, Adam Price, Allison L. Richards, Mark T.A. Donoghue, James Lindsay, Bijaya Sharma, Madison Turner, Kathleen L. Pfaff, Kristen D. Felt, Scott J. Rodig, Xihong Lin, Matthew L. Meyerson, Bruce E. Johnson, David C. Christiani, Adam J. Schoenfeld, Mark M. Awad

2023Journal of Thoracic Oncology42 citationsDOIOpen Access PDF

Topics & Concepts

MedicineAneuploidyOncologyImmunotherapyInternal medicineBiomarkerLung cancerCancerChromosomeCancer researchGeneGeneticsBiologyCancer Immunotherapy and BiomarkersImmunotherapy and Immune ResponsesFerroptosis and cancer prognosis
Impact of Aneuploidy and Chromosome 9p Loss on Tumor Immune Microenvironment and Immune Checkpoint Inhibitor Efficacy in NSCLC | Litcius